Essential Characteristics of Pharmacogenomics Study Publications
Lists
Only you see this
Abstract
Pharmacogenomics (PGx) can be seen as a model for biomedical studies: it includes all disease areas of interest and spans in vitro studies to clinical trials, while focusing on the relationships between genes and drugs and the resulting phenotypes. This review will examine different characteristics of PGx study publications and provide examples of excellence in framing PGx questions and reporting their resulting data in a way that maximizes the knowledge that can be built on them.
BibTeX
@inproceedings{thorn2018essential,
author = {Caroline F. Thorn and Michelle Whirl‐Carrillo and Houda Hachad and Julie A. Johnson and Ellen M. McDonagh and Mark J. Ratain and Mary V. Relling and Stuart A. Scott and Russ B. Altman and Teri E. Klein},
title = {{Essential Characteristics of Pharmacogenomics Study Publications}},
booktitle = {Clinical},
year = {2018},
doi = {10.1002/cpt.1279},
}Loading related content...